HA | Aktsiad | 25,99 M | — | HA Hanwha | 0,40 | Tervishoiu | KRX 300 Healthcare Index - KRW - Benchmark TR Gross | 8.11.2018 | 7972,52 | 4,05 | 49,35 |
XT | Aktsiad | 25,41 M | — | XT Xtrackers | 0,35 | Tervishoiu | MSCI ACWI IMI SDG 3 Good Health and Well-being Select Index - Benchmark TR Net | 18.1.2023 | 35,36 | 4,42 | 20,67 |
LG | Aktsiad | 24,51 M | 1079 | LG L&G | 0,49 | Tervishoiu | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 14,21 | 3,62 | 18,36 |
FU | Aktsiad | 20,48 M | — | FU Fubon | 0,60 | Tervishoiu | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 3.3.2022 | 0,69 | 0,00 | 0,00 |
JH | Aktsiad | 20,34 M | 10 491 | JH John Hancock Investments | 0,40 | Tervishoiu | John Hancock Dimensional Healthcare Index | 28.9.2015 | 45,19 | 4,05 | 17,36 |
BO | Aktsiad | 19,56 M | — | BO Bosera | 0,60 | Tervishoiu | CSI Vaccine and Biotechnology Index - CNY - Benchmark TR Gross | 8.11.2022 | 0,52 | 0,00 | 0,00 |
| Aktsiad | 18,86 M | 1683 | GO Goldman | 0,75 | Tervishoiu | | 9.11.2021 | 35,93 | 7,30 | 29,06 |
LG | Aktsiad | 18,52 M | 1516 | LG L&G | 0,49 | Tervishoiu | Solactive Pharma Breakthrough Value Index | 23.1.2018 | 10,74 | 3,62 | 18,36 |
DI | Aktsiad | 17,55 M | 90 290 | DI Direxion | 1,31 | Tervishoiu | | 26.3.2025 | 28,08 | 0,00 | 0,00 |
FT | Aktsiad | 17,53 M | 5077 | FT First Trust | 0,60 | Tervishoiu | NYSE Arca Biotechnology Index | 27.5.2020 | 31,87 | 3,45 | 22,71 |
| Aktsiad | 16,58 M | 2031 | HK Horizon Kinetics | 0,85 | Tervishoiu | | 27.1.2023 | 35,29 | 5,70 | 22,16 |
DI | Aktsiad | 16,26 M | 64 287 | DI Direxion | 1,22 | Tervishoiu | S&P Pharmaceuticals Select Industry | 15.11.2017 | 14,78 | 0,00 | 0,00 |
PF | Aktsiad | 16,16 M | 1776 | PF Principal Funds | 0,42 | Tervishoiu | BTEC-US - No Underlying Index | 22.8.2016 | 39,41 | 4,34 | 0,00 |
BM | Aktsiad | 15,75 M | — | BM BMO | 0,00 | Tervishoiu | S&P Health Care Select Sector | 21.1.2025 | 28,20 | 0,00 | 0,00 |
IN | Aktsiad | 15,19 M | — | IN Invesco | 0,18 | Tervishoiu | S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care Index - Benchmark TR Net | 12.4.2023 | 6,21 | 4,97 | 23,13 |
HE | Aktsiad | 14,46 M | — | HE Harvest ETFs | 1,06 | Tervishoiu | | 27.2.2020 | 8,37 | 0,00 | 0,00 |
IS | Aktsiad | 13,74 M | 1993 | IS iShares | 0,77 | Tervishoiu | | 29.9.2020 | 34,34 | 4,69 | 23,25 |
| Aktsiad | 13,45 M | — | TA Tachlit | 0,50 | Tervishoiu | S&P Health Care Select Sector | 13.11.2018 | 171,70 | 0,00 | 0,00 |
YI | Alternatiivvara | 13,4 M | 51 893 | YI YieldMax | 1,01 | Tervishoiu | | 25.9.2025 | 11,91 | 0,00 | 0,00 |
FT | Aktsiad | 13,25 M | 2232 | FT First Trust | 0,60 | Tervishoiu | NYSE Arca Biotechnology Index | 27.5.2020 | 24,09 | 3,45 | 22,71 |
| Aktsiad | 12,73 M | 2147 | RA Range | 0,79 | Tervishoiu | Range Oncology Therapeutics Index | 14.10.2015 | 13,68 | 1,22 | 0,00 |
HA | Aktsiad | 12,72 M | 6440 | HA HANetf | 0,89 | Tervishoiu | Indxx Advanced Life Sciences & Smart Healthcare Thematic Index | 4.4.2019 | 7,09 | 9,44 | 30,16 |
EV | Aktsiad | 12,41 M | — | EV Evolve | 0,72 | Tervishoiu | Solactive Global Healthcare 20 Index - Benchmark TR Net | 27.11.2019 | 18,28 | 0,00 | 0,00 |
BM | Aktsiad | 11,65 M | 574 | BM BMO | 0,40 | Tervishoiu | Solactive Equal Weight U.S Health Care Index - CAD | 12.2.2019 | 52,72 | 3,68 | 20,81 |
| Aktsiad | 10,99 M | — | TA Tachlit | 0,83 | Tervishoiu | S&P Health Care Select Sector | 27.11.2018 | 43,73 | 0,00 | 0,00 |
IN | Aktsiad | 10,77 M | 110 | IN Invesco | 0,20 | Tervishoiu | STOXX Europe 600 Optimised Health Care Index - EUR | 8.7.2009 | 405,47 | 3,50 | 20,50 |
VA | Aktsiad | 10,61 M | — | VA VanEck | 0,00 | Tervishoiu | MVIS Global Bionic Healthcare ESG Index - Benchmark TR Net | 2.12.2022 | 18,52 | 3,60 | 27,00 |
GR | etf_assetclass_Leveraged/Inverse | 10,53 M | 71 950 | GR GraniteShares | 1,50 | Tervishoiu | | 7.10.2025 | 16,99 | 0,00 | 0,00 |
TE | Aktsiad | 10,28 M | 83 | TE Tema | 0,75 | Tervishoiu | | 22.1.2024 | 23,37 | 3,94 | 29,55 |
| Aktsiad | 9,97 M | 534 | LO Loncar | 0,79 | Tervishoiu | Loncar China BioPharma | 15.8.2018 | 9,77 | 1,73 | 12,13 |
AM | Aktsiad | 9,68 M | 1202 | AM Amplify | 0,68 | Tervishoiu | Prime Treatments, Testing and Advancements Index - USD | 18.6.2020 | 19,34 | 2,17 | 13,17 |
FT | etf_assetclass_Sector Equity | 9,37 M | 3714 | FT First Trust | 0,65 | Tervishoiu | NASDAQ Lux Health Tech Index | 22.3.2022 | 23,43 | 4,66 | 26,17 |
HO | Aktsiad | 9,26 M | — | HO Horizons | 1,63 | Tervishoiu | North American Psychedelics Index - CAD | 26.1.2021 | 6,58 | 1,92 | 0,00 |
| Aktsiad | 9,1 M | — | IT Itau | 0,00 | Tervishoiu | Morningstar US Exponential Technologies Healthcare Index - Benchmark TR Gross | 9.6.2021 | 55,41 | 3,89 | 24,16 |
JM | etf_assetclass_International Equity | 9,07 M | 374 | JM J.P. Morgan | 0,65 | Tervishoiu | | 1.11.2023 | 60,46 | 4,96 | 22,26 |
FI | Aktsiad | 8,39 M | 2781 | FI Fidelity | 0,39 | Tervishoiu | Fidelity Digital Health Index | 5.10.2021 | 20,05 | 3,85 | 37,90 |
FT | Aktsiad | 8,37 M | 51 | FT First Trust | 0,70 | Tervishoiu | StrataQuant Health Care Index | 29.10.2014 | 50,02 | 3,02 | 17,23 |
DE | Aktsiad | 8,24 M | 2447 | DE Defiance | 0,45 | Tervishoiu | NASDAQ Junior Biotechnology Index | 3.8.2020 | 29,93 | 5,24 | 0,00 |
BM | Aktsiad | 8,13 M | — | BM BMO | 0,00 | Tervishoiu | | 26.6.2023 | 18,04 | 0,00 | 0,00 |
GR | etf_assetclass_Leveraged/Inverse | 7,78 M | — | GR GraniteShares | 8,80 | Tervishoiu | Solactive Daily Leveraged 3x long Moderna Index - Benchmark TR Net | 30.8.2021 | 292,36 | 0,00 | 0,00 |
GX | Aktsiad | 7,47 M | 13 491 | GX Global X | 0,65 | Tervishoiu | MSCI China Health Care 10-50 | 11.12.2018 | 12,45 | 2,24 | 15,02 |
| Aktsiad | 7,27 M | — | IN Investo | 0,00 | Tervishoiu | S&P Biotechnology Select Industry | 15.12.2021 | 59,86 | 0,00 | 0,00 |
IS | Aktsiad | 6,36 M | 2973 | IS iShares | 0,47 | Tervishoiu | NYSE FactSet Global Neuro Biopharma and MedTech Index | 24.8.2022 | 31,79 | 4,64 | 16,48 |
GX | Aktsiad | 5,78 M | 2919 | GX Global X | 0,68 | Tervishoiu | Solactive Telemedicine & Digital Health Index- TR Net | 17.12.2020 | 10,18 | 3,22 | 29,60 |
AM | Aktsiad | 5,63 M | 1780 | AM Amplify | 0,59 | Tervishoiu | VettaFi Weight Loss Drug & Treatment Index - Benchmark TR Net | 21.5.2024 | 24,48 | 5,28 | 19,73 |
| Aktsiad | 5,07 M | — | MU Mulvihill | 0,00 | Tervishoiu | | 31.1.2023 | 7,73 | 4,06 | 25,89 |
RI | Aktsiad | 4,84 M | 6167 | RI Roundhill Investments | 0,99 | Tervishoiu | | 3.12.2025 | 44,03 | 0,00 | 0,00 |
DE | Aktsiad | 4,68 M | 7146 | DE Defiance | 0,75 | Tervishoiu | | 27.5.2021 | 5,93 | 0,00 | 0,00 |
| Aktsiad | 4,66 M | — | CI CIRCA5000 | 0,49 | Tervishoiu | Impak CIRCA5000 Health & Wellbeing Impact Index - Benchmark TR Net | 5.6.2023 | 5,22 | 0,00 | 0,00 |
| etf_assetclass_US Equity | 4,53 M | 15 936 | RE Rexshares | 0,99 | Tervishoiu | | 4.11.2025 | 23,85 | 0,00 | 0,00 |
BM | Aktsiad | 4,36 M | — | BM BMO | 0,00 | Tervishoiu | S&P Health Care Select Sector | 21.1.2025 | 28,54 | 0,00 | 0,00 |
HE | Aktsiad | 4,34 M | — | HE Harvest ETFs | 0,00 | Tervishoiu | | 21.8.2024 | 8,09 | 0,00 | 0,00 |
CI | Aktsiad | 4,3 M | — | CI CI | 0,84 | Tervishoiu | | 7.6.2018 | 12,29 | 0,00 | 0,00 |
| Aktsiad | 4,16 M | — | KS KSM | 0,00 | Tervishoiu | STOXX Europe 600 / Health Care (Capped) - SS | 20.11.2018 | 429,28 | 0,00 | 0,00 |
AN | Aktsiad | 3,98 M | 8882 | AN Anfield | 0,00 | Tervishoiu | MarketGrader Global Health Care Leaders Index | 21.9.2021 | 8,91 | 4,00 | 12,63 |
HE | Aktsiad | 3,96 M | — | HE Harvest ETFs | 0,00 | Tervishoiu | | 15.1.2026 | 6,46 | 0,00 | 0,00 |
TR | Aktsiad | 3,96 M | 35 128,46 | TR Tradr | 1,30 | Tervishoiu | | 22.10.2025 | 10,41 | 0,00 | 0,00 |
FT | Aktsiad | 3,89 M | — | FT First Trust | 0,73 | Tervishoiu | NYSE Arca Biotechnology Index | 17.2.2021 | 35,32 | 28,29 | 30,59 |
| Aktsiad | 3,68 M | — | KE KellyETFs | 0,78 | Tervishoiu | NYSE FactSet Global Genomics and Immuno Biopharma Index | 13.1.2022 | 10,50 | 2,86 | 14,62 |
| Aktsiad | 3,67 M | 1568 | AH ADR hedged | 0,19 | Tervishoiu | | 2.1.2025 | 21,57 | 0,00 | 0,00 |
| Aktsiad | 3,55 M | 12 202 | LE LeverageShares | 0,75 | Tervishoiu | iSTOXX Leveraged 3x MRNA Index - Benchmark TR Net | 14.12.2021 | 121,84 | 0,00 | 0,00 |
PR | Aktsiad | 3,49 M | 7655 | PR ProShares | 6,64 | Tervishoiu | S&P Health Care Select Sector | 30.1.2007 | 14,51 | 0,00 | 0,00 |
TD | Aktsiad | 3,46 M | — | TD TD | 0,45 | Tervishoiu | Solactive Global Healthcare Leaders Index | 2.5.2022 | 13,66 | 0,00 | 0,00 |
DI | Aktsiad | 3,19 M | 3909 | DI Direxion | 0,99 | Tervishoiu | UnitedHealth Group Incorporated | 25.3.2026 | 42,47 | 0,00 | 0,00 |
FT | etf_assetclass_Sector Equity | 3,15 M | 2504 | FT First Trust | 0,70 | Tervishoiu | Indxx Global Medical Equipment Index | 22.6.2021 | 20,98 | 2,93 | 26,01 |
DI | Aktsiad | 3,13 M | 81 | DI Direxion | 0,00 | Tervishoiu | BITA Messenger RNA Technology Index - Benchmark TR Net | 9.12.2021 | 13,76 | 3,69 | 0,00 |
DI | Aktsiad | 3,06 M | 18 827 | DI Direxion | 1,99 | Tervishoiu | Eli Lilly and Co. - USD - Benchmark Price Return | 26.3.2025 | 20,42 | 0,00 | 0,00 |
GX | Aktsiad | 3,01 M | 725 | GX Global X | 0,65 | Tervishoiu | Cboe S&P Health Care Select Sector Half BuyWrite Index - Benchmark TR Gross | 23.11.2022 | 25,10 | 5,04 | 27,46 |
FT | Aktsiad | 2,93 M | 11 | FT Franklin Templeton | 0,30 | Tervishoiu | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 29,28 | 3,22 | 18,08 |
FI | Aktsiad | 2,89 M | — | FI Fidelity | 0,50 | Tervishoiu | Fidelity Digital Health ESG Tilted Index - Benchmark TR Net | 24.8.2022 | 5,42 | 0,00 | 0,00 |
FT | Aktsiad | 2,89 M | — | FT Franklin Templeton | 0,30 | Tervishoiu | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 28,87 | 3,22 | 18,08 |
FT | Aktsiad | 2,89 M | — | FT Franklin Templeton | 0,30 | Tervishoiu | Solactive Sustainable Health and Wellness Index | 5.7.2023 | 28,87 | 3,22 | 18,08 |
FT | Aktsiad | 2,88 M | — | FT First Trust | 0,82 | Tervishoiu | StrataQuant Health Care Index - CAD | 8.12.2017 | 28,81 | 0,00 | 0,00 |
| Aktsiad | 2,78 M | — | TA Tachlit | 0,30 | Tervishoiu | NASDAQ / Biotechnology | 27.11.2018 | 30,55 | 0,00 | 0,00 |
GX | Aktsiad | 2,71 M | — | GX Global X | 0,00 | Tervishoiu | VettaFi Equal Weight Global Healthcare Index - CAD - Benchmark TR Net | 30.4.2025 | 21,64 | 0,00 | 0,00 |
DI | Aktsiad | 2,69 M | 3758 | DI Direxion | 6,27 | Tervishoiu | NYSE Biotechnology Top 5 Equal Weight Index - Benchmark TR Gross | 1.10.2025 | 35,88 | 0,00 | 0,00 |
| Aktsiad | 2,59 M | 5044 | KE KellyETFs | 0,78 | Tervishoiu | Strategic CRISPR & Gene Editing Technology Index - Benchmark TR Gross | 13.1.2022 | 7,38 | 1,68 | 17,02 |
DE | Aktsiad | 2,58 M | 47 567 | DE Defiance | 1,51 | Tervishoiu | | 18.8.2025 | 5,17 | 0,00 | 0,00 |
| Aktsiad | 2,49 M | 2995 | LA Langar | 0,85 | Tervishoiu | | 9.1.2024 | 10,83 | 3,48 | 25,34 |
CI | Aktsiad | 2,33 M | — | CI CI | 0,85 | Tervishoiu | | 3.3.2022 | 9,28 | 0,00 | 0,00 |
HO | Aktsiad | 2,03 M | — | HO Horizons | 1,19 | Tervishoiu | Solactive Global Vaccines and Infectious Diseases Index - CAD - Benchmark TR Net | 26.10.2021 | 15,47 | 0,00 | 0,00 |
HE | Aktsiad | 2,03 M | — | HE Harvest ETFs | 0,00 | Tervishoiu | | 15.1.2026 | 13,49 | 0,00 | 0,00 |
PU | Aktsiad | 1,93 M | — | PU Purpose | 1,27 | Tervishoiu | | 4.10.2021 | 19,26 | 4,48 | 18,17 |
PR | Aktsiad | 1,91 M | 7990 | PR ProShares | 3,20 | Tervishoiu | NASDAQ / Biotechnology | 7.4.2010 | 11,53 | 0,00 | 0,00 |
| Aktsiad | 1,91 M | 21 608 | PS PSYK | 0,75 | Tervishoiu | Enhanced Consciousness Index - Benchmark TR Net | 31.1.2022 | 16,46 | 2,18 | 0,00 |
KR | Aktsiad | 1,9 M | 129 | KR KraneShares | 0,79 | Tervishoiu | Solactive Emerging Markets Healthcare Index NTR | 28.8.2018 | 18,99 | 3,09 | 26,95 |
BE | Aktsiad | 1,68 M | — | BE BetaShares | 0,67 | Tervishoiu | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net | 30.3.2022 | 10,54 | 3,36 | 39,43 |
DE | Aktsiad | 1,54 M | 87 899 | DE Defiance | 1,29 | Tervishoiu | | 2.9.2025 | 8,55 | 0,00 | 0,00 |
| Aktsiad | 1,5 M | 4380 | AD ADRhedged | 0,19 | Tervishoiu | AstraZeneca PLC - Benchmark Price Return | 7.10.2024 | 50,52 | 0,00 | 0,00 |
KR | Aktsiad | 1,5 M | 484 | KR KraneShares | 0,65 | Tervishoiu | MSCI China All Shares Health Care 10/40 Index | 14.1.2021 | 9,98 | 2,55 | 19,00 |
GX | Aktsiad | 1,41 M | 712 | GX Global X | 0,65 | Tervishoiu | Solactive China Biotech Innovation Index | 25.9.2020 | 6,72 | 2,41 | 18,61 |
HE | Aktsiad | 1,37 M | — | HE Harvest ETFs | 0,00 | Tervishoiu | | 21.8.2024 | 8,98 | 0,00 | 0,00 |
GR | etf_assetclass_Leveraged/Inverse | 1,31 M | 806 | GR GraniteShares | 3,24 | Tervishoiu | Solactive Daily Leveraged 3x long BP Index | 4.11.2019 | 20,79 | 0,00 | 0,00 |
HO | Aktsiad | 1,1 M | — | HO Horizons | 0,89 | Tervishoiu | Solactive Telemedicine & Digital Health Index- TR Net | 2.11.2021 | 18,30 | 0,00 | 0,00 |
BM | Aktsiad | 1,09 M | — | BM BMO | 0,00 | Tervishoiu | | 9.2.2026 | 42,86 | 0,00 | 0,00 |
AI | Aktsiad | 892 679 | 163 | AI AXS Investments | 1,15 | Tervishoiu | Pfizer Inc. | 13.7.2022 | 51,63 | 0,00 | 0,00 |
BF | Aktsiad | 806 325 | — | BF Brompton Funds | 0,75 | Tervishoiu | | 8.8.2019 | 8,27 | 0,00 | 0,00 |
| Aktsiad | 800 500 | 1254 | LE LeverageShares | 0,75 | Tervishoiu | | 18.12.2025 | 32,02 | 0,00 | 0,00 |
GR | Alternatiivvara | 753 803 | 4734 | GR GraniteShares | 1,07 | Tervishoiu | | 2.12.2025 | 5,38 | 0,00 | 0,00 |
GR | Aktsiad | 706 216,1 | — | GR GraniteShares | 0,99 | Tervishoiu | Solactive Daily Leveraged 3x short Moderna Index - EUR - Benchmark TR Net | 30.8.2021 | 3,76 | 0,00 | 0,00 |